Related Experiment Video
Updated: Jul 5, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
The p815 mastocytoma tumor model
T F Gajewski1, M A Markiewicz, C Uyttenhove
1The University of Chicago, Chicago, Illinois, USA.
Current Protocols in Immunology
|April 25, 2008
Summary
This study introduces a P815 mastocytoma tumor model in mice, crucial for advancing tumor immunology and developing cancer vaccines for melanoma. The model facilitates research into anti-tumor responses and immune system interactions.
Area of Science:
- Tumor Immunology
- Cancer Research
- Preclinical Models
Background:
- The P815 mastocytoma cell line provides a valuable tool for in vivo tumor research.
- Understanding the tumor-host relationship is critical for developing effective cancer therapies.
Purpose of the Study:
- To present an experimental tumor model for advancing tumor immunology.
- To facilitate the preclinical development of human cancer vaccines for melanoma.
Main Methods:
- Utilized the P815 mastocytoma cell line in syngeneic DBA/2 mice.
- Implanted tumors intraperitoneally and subcutaneously.
- Created immunogenic variants for studying tumor rejection.
Main Results:
- The P815 model allows progressive tumor growth in mice.
- Spontaneous rejection of immunogenic tumor variants was observed.
- The model enables the study of molecules and cells involved in anti-tumor responses.
Conclusions:
- The P815 mastocytoma model is pivotal for tumor immunology research.
- This model supports the preclinical development of melanoma cancer vaccines.
- It offers insights into the mechanisms of successful anti-tumor immunity.
